Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jesse Hinckley to Humans

This is a "connection" page, showing publications Jesse Hinckley has written about Humans.

 
Connection Strength
 
 
 
0.228
 
  1. Molinero K, Hinckley JD. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Psychiatr Clin North Am. 2023 12; 46(4):691-702.
    View in: PubMed
    Score: 0.025
  2. Adams ZW, Marriott BR, Hulvershorn LA, Hinckley JD. Treatment of Adolescent Cannabis Use Disorders. Psychiatr Clin North Am. 2023 12; 46(4):775-788.
    View in: PubMed
    Score: 0.025
  3. Adams ZW, Marriott BR, Hulvershorn LA, Hinckley J. Treatment of Adolescent Cannabis Use Disorders. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):141-155.
    View in: PubMed
    Score: 0.023
  4. Molinero K, Hinckley JD. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):57-68.
    View in: PubMed
    Score: 0.023
  5. Hinckley J, Bhatia D, Ellingson J, Molinero K, Hopfer C. The impact of recreational cannabis legalization on youth: the Colorado experience. Eur Child Adolesc Psychiatry. 2024 Mar; 33(3):637-650.
    View in: PubMed
    Score: 0.022
  6. Winters DE, Brandon-Friedman R, Yepes G, Hinckley JD. Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use. Drug Alcohol Depend. 2021 02 01; 219:108479.
    View in: PubMed
    Score: 0.020
  7. Hinckley JD, Saba L, Raymond K, Bartels K, Klawitter J, Christians U, Hopfer C. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses. Cannabis Cannabinoid Res. 2022 02; 7(1):65-77.
    View in: PubMed
    Score: 0.020
  8. Hinckley JD, Riggs P. Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder. Child Adolesc Psychiatr Clin N Am. 2019 07; 28(3):461-472.
    View in: PubMed
    Score: 0.018
  9. Hinckley J, Di Paola J. Genetic basis of congenital platelet disorders. Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):337-42.
    View in: PubMed
    Score: 0.013
  10. Riggs P, Hinckley JD, Ross JM. Addressing Cannabis Use During Adolescence. Psychiatr Clin North Am. 2023 12; 46(4):xiii-xv.
    View in: PubMed
    Score: 0.006
  11. Olsavsky AK, Hinckley JD, Vidal C. Editorial: Marijuana Legalization and Suicide in Adolescents and Transitional-Age Youth: Important Future Directions for This Line of Research. J Am Acad Child Adolesc Psychiatry. 2024 Mar; 63(3):307-309.
    View in: PubMed
    Score: 0.006
  12. Riggs P, Hinckley JD, Ross JM. Addressing Cannabis Use During Adolescence. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):xiii-xv.
    View in: PubMed
    Score: 0.006
  13. Bhatia D, Hinckley J, Mikulich S, Sakai J. Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes. J Addict Med. 2022 Jan-Feb 01; 16(1):e16-e22.
    View in: PubMed
    Score: 0.005
  14. Gupta S, Heiman M, Duncan N, Hinckley J, Di Paola J, Shapiro AD. Variable bleeding phenotype in an Amish pedigree with von Willebrand disease. Am J Hematol. 2016 Oct; 91(10):E431-5.
    View in: PubMed
    Score: 0.004
  15. Chen J, Hinckley JD, Haberichter S, Jacobi P, Montgomery R, Flood VH, Wong R, Interlandi G, Chung DW, L?pez JA, Di Paola J. Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease. Blood. 2015 Jul 09; 126(2):262-9.
    View in: PubMed
    Score: 0.003
  16. Noetzli L, Sanz PG, Brodsky GL, Hinckley JD, Giugni JC, Giannaula RJ, Gonzalez-Alegre P, Di Paola J. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2. Gene. 2014 Jan 01; 533(1):447-50.
    View in: PubMed
    Score: 0.003
  17. Kahr WH, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW, Pluthero FG, Urban D, Fabbro S, Nixon B, Gadzinski R, Storck M, Wang K, Ryu GY, Jobe SM, Schutte BC, Moseley J, Loughran NB, Parkinson J, Weyrich AS, Di Paola J. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet. 2011 Jul 17; 43(8):738-40.
    View in: PubMed
    Score: 0.003
  18. Fabbro S, Kahr WH, Hinckley J, Wang K, Moseley J, Ryu GY, Nixon B, White JG, Bair T, Schutte B, Di Paola J. Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly. Blood. 2011 Mar 24; 117(12):3430-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)